Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission – confounded by the gut microbiome? Authors’ reply.

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission – confounded by the gut microbiome? Authors’ reply.

Aliment Pharmacol Ther. 2019 Apr;49(8):1087-1088

Authors: Bond A, Probert C

PMID: 30920048 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/30920048?dopt=Abstract